Trending News: Several Walmart- and Walgreen-Exclusive Eye Drops Recalled

Several eye drops and ointments exclusively sold at Walmart and Walgreen stores have been recalled because they might not be sterile, according to an article by CNN. Altaire Pharmaceuticals Inc. issued voluntary recalls for various Equate products, including for allergy relief, solutions, eye drops, and gel drops sold at Walmart. The company has also issued recalls for several over-the-counter and prescription eye drops and ophthamlmic ointments under the brand name Walgreens.
 
The World Health Organization has published an updated list of “essential medicines” today, according to Reuters. The list added drugs for cancer, stroke, rheumatoid arthritis, and inflammatory bowel disease among the treatments that should be seen as the standard. The list also included 5 new cancer therapies based on improved survival rates for lung, blood, and prostate cancers, and recommended 2 new immunotherapies, nivolumab and pembrolizumab.
 
The FDA has accepted 6 supplemental sBLASs to update the dosing frequency of pembrolizumab to include an every-six-weeks dosing schedule option, according to Merck. If approved, the Q6W dose would be available for use in adults in addition to the currently approved soe of 200 mg every 3 weeks infused over 30 minutes. The FDA has set a Prescription Drug User Fee Act (PDUFA), or target action, date of Feb. 18, 2020.



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Related Articles

Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$